{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:47:42Z","timestamp":1785322062635,"version":"3.55.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T00:00:00Z","timestamp":1557360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870462"],"award-info":[{"award-number":["81870462"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470990"],"award-info":[{"award-number":["81470990"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Science and Technology Commission of Shanghai Municipality","award":["17441904200"],"award-info":[{"award-number":["17441904200"]}]},{"name":"the Shanghai Pudong New Area Program","award":["PW2015D-4"],"award-info":[{"award-number":["PW2015D-4"]}]},{"name":"the Shanghai Ninth People\u2019s Hospital Clinical Research Program","award":["JYLJ007"],"award-info":[{"award-number":["JYLJ007"]}]},{"name":"the Shanghai Ninth People\u2019s Hospital MDT Program","award":["2017-1-019"],"award-info":[{"award-number":["2017-1-019"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Protein-bound uremic toxins (PBUTs) have received extensive attention, as their accumulation leads to pleiotropic toxic biological effects, while the removal of these solutes by conventional dialysis therapies is severely hampered. This study aimed to examine whether increased removal of PBUTs could be achieved with intravenous lipid emulsion (ILE).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>PBUTs such as 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid (CMPF), p-cresyl sulfate (PCS) and indoxyl sulfate (IS) were spiked with human serum albumin (HSA) solution and the inhibitory effects of free fatty acid (FFA) on the binding of CMPF, PCS and IS to HSA were examined separately in vitro by ultrafiltration. In vitro dialysis of albumin solution was then performed to investigate the effects of fatty acid (FAs) mixtures infusion on the fractional removal of PBUTs. Finally, the inhibitory effect of FFA on the binding of PBUTs to albumin was examined in uremic rats, and blood purification therapy was conducted to calculate the reduction ratio (RR) and the total solute removal (TSR) of solutes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The percentage protein binding of CMPF, PCS and IS decreased significantly with increasing FFAs concentrations, and the inhibitory effect was more remarkable with the addition of oleic acid or linoleic acid than that of eicosapentaenoic acid and docosahexaenoic acid. In vitro infusion of FAs increased the fractional removal of CMPF to 14.40\u2009\u00b1\u20092.38%. PCS, IS and indole-3-acetic acid removal increased from 8.00\u2009\u00b1\u20092.43%, 11.68\u2009\u00b1\u20091.54% and 15.38\u2009\u00b1\u20093.97%, respectively, at baseline to 28.21\u2009\u00b1\u20095.99%, 35.42\u2009\u00b1\u20095.27% and 40.18\u2009\u00b1\u20095.05%, respectively, when FAs were present. In vivo, rat serum concentrations of free PBUTs were significantly higher in the ILE group than in the control group, and administration of ILE resulted in higher RRs and more TSR for PBUTs after 3\u2009h of hemodialysis (HD) therapy compared with the control group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Administration of ILE effectively increased the dialytic removal of PBUTs. This method could be applied to current HD therapy.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ndt\/gfz079","type":"journal-article","created":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T12:09:28Z","timestamp":1553861368000},"page":"1842-1852","source":"Crossref","is-referenced-by-count":25,"title":["Improved dialytic removal of protein-bound uremic toxins by intravenous lipid emulsion in chronic kidney disease rats"],"prefix":"10.1093","volume":"34","author":[{"given":"Yuanyuan","family":"Shi","sequence":"first","affiliation":[{"name":"Division of Nephrology & Unit of Critical Nephrology, Shanghai Ninth People\u2019s Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Nephrology & Unit of Critical Nephrology, Shanghai Ninth People\u2019s Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajun","family":"Tian","sequence":"additional","affiliation":[{"name":"Division of Nephrology & Unit of Critical Nephrology, Shanghai Ninth People\u2019s Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Nephrology & Unit of Critical Nephrology, Shanghai Ninth People\u2019s Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Shen","sequence":"additional","affiliation":[{"name":"Division of Nephrology & Unit of Critical Nephrology, Shanghai Ninth People\u2019s Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Division of Nephrology & Unit of Critical Nephrology, Shanghai Ninth People\u2019s Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ding","sequence":"additional","affiliation":[{"name":"Division of Nephrology & Unit of Critical Nephrology, Shanghai Ninth People\u2019s Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,5,9]]},"reference":[{"key":"2019110402561249400_gfz079-B1","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"Review on uremic toxins: classification, concentration, and interindividual variability","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int"},{"key":"2019110402561249400_gfz079-B2","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1681\/ASN.2011121175","article-title":"Normal and pathologic concentrations of uremic toxins","volume":"23","author":"Duranton","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2019110402561249400_gfz079-B3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000189035","article-title":"Hypothesis: is accumulation of a furan dicarboxylic acid (3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid) related to the neurological abnormalities in patients with renal failure?","volume":"73","author":"Costigan","year":"1996","journal-title":"Nephron"},{"key":"2019110402561249400_gfz079-B4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2265.1994.tb02447.x","article-title":"Transport of thyroxine into cultured hepatocytes: effects of mild non-thyroidal illness and calorie restriction in obese subjects","volume":"40","author":"Lim","year":"1994","journal-title":"Clin Endocrinol"},{"key":"2019110402561249400_gfz079-B5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.tem.2016.04.010","article-title":"CMPF: a biomarker for type 2 diabetes mellitus progression?","volume":"27","author":"Koppe","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"2019110402561249400_gfz079-B6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.cmet.2014.03.008","article-title":"The furan fatty acid metabolite CMPF is elevated in diabetes and induces beta cell dysfunction","volume":"19","author":"Prentice","year":"2014","journal-title":"Cell Metab"},{"key":"2019110402561249400_gfz079-B7","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1681\/ASN.2013101062","article-title":"The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review","volume":"25","author":"Vanholder","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"2019110402561249400_gfz079-B8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/toxins8120358","article-title":"Indoxyl sulfate-review of toxicity and therapeutic strategies","volume":"8","author":"Leong","year":"2016","journal-title":"Toxins"},{"key":"2019110402561249400_gfz079-B9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/toxins9020052","article-title":"p-Cresyl sulfate","volume":"9","author":"Gryp","year":"2017","journal-title":"Toxins (Basel)"},{"key":"2019110402561249400_gfz079-B10","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1681\/ASN.2013121283","article-title":"The cardiovascular effect of the uremic solute indole-3 acetic acid","volume":"26","author":"Dou","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2019110402561249400_gfz079-B11","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1681\/ASN.2005030310","article-title":"Removal of P-cresol sulfate by hemodialysis","volume":"16","author":"Martinez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2019110402561249400_gfz079-B12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000350843","article-title":"Removal of protein-bound uraemic toxins by haemodialysis","volume":"35","author":"Niwa","year":"2013","journal-title":"Blood Purif"},{"key":"2019110402561249400_gfz079-B13","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1046\/j.1523-1755.2003.00310.x","article-title":"Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms","volume":"64","author":"Bammens","year":"2003","journal-title":"Kidney Int"},{"key":"2019110402561249400_gfz079-B14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1053\/j.ajkd.2007.12.035","article-title":"A review of albumin binding in CKD","volume":"51","author":"Meijers","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"2019110402561249400_gfz079-B15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0272-6386(89)80116-7","article-title":"The effect of renal transplantation on a major endogenous ligand retained in uremic serum","volume":"13","author":"Mabuchi","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"2019110402561249400_gfz079-B16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.arcmed.2013.09.007","article-title":"Gastrointestinal-related uremic toxins in peritoneal dialysis: a pilot study with a 5-year follow-up","volume":"44","author":"Lin","year":"2013","journal-title":"Arch Med Res"},{"key":"2019110402561249400_gfz079-B17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biochi.2017.09.018","article-title":"Using binding competitors of albumin to promote the removal of protein-bound uremic toxins in hemodialysis: hope or pipe dream?","volume":"144","author":"Florens","year":"2018","journal-title":"Biochimie"},{"key":"2019110402561249400_gfz079-B18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/MAT.0000000000000166","article-title":"Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration","volume":"61","author":"Bohringer","year":"2015","journal-title":"Asaio J"},{"key":"2019110402561249400_gfz079-B19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/apha.12730","article-title":"Haemodiafiltration at increased plasma ionic strength for improved protein-bound toxin removal","volume":"219","author":"Krieter","year":"2017","journal-title":"Acta Physiol"},{"key":"2019110402561249400_gfz079-B20","doi-asserted-by":"crossref","first-page":"23389","DOI":"10.1038\/srep23389","article-title":"Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood study","volume":"6","author":"Tao","year":"2016","journal-title":"Sci Rep"},{"key":"2019110402561249400_gfz079-B21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jemermed.2014.10.009","article-title":"Intravenous lipid emulsion in the emergency department: a systematic review of recent literature","volume":"48","author":"Cao","year":"2015","journal-title":"J Emerg Med"},{"key":"2019110402561249400_gfz079-B22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1742-6723.2011.01398.x","article-title":"Intravenous lipid emulsion as antidote: a summary of published human experience","volume":"23","author":"Cave","year":"2011","journal-title":"Emerg Med Australas"},{"key":"2019110402561249400_gfz079-B23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","article-title":"Human serum albumin: from bench to bedside","volume":"33","author":"Fanali","year":"2012","journal-title":"Mol Aspects Med"},{"key":"2019110402561249400_gfz079-B24","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1523-1755.2005.00469.x","article-title":"The clearance of protein-bound solutes by hemofiltration and hemodiafiltration","volume":"68","author":"Meyer","year":"2005","journal-title":"Kidney Int"},{"key":"2019110402561249400_gfz079-B25","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jchromb.2011.06.014","article-title":"Determination of uremic solutes in biological \ufb02uids of chronic kidney disease patients by HPLC assay","volume":"879","author":"Calaf","year":"2011","journal-title":"J. Chromatogr B"},{"key":"2019110402561249400_gfz079-B26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0378-4347(00)83197-7","article-title":"Determination of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, a major endogenous ligand substance in uremic serum, by high-performance liquid chromatography with ultraviolet detection","volume":"415","author":"Mabuchi","year":"1987","journal-title":"J Chromatogr"},{"key":"2019110402561249400_gfz079-B27","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1016\/j.bbagen.2013.05.005","article-title":"Albumin-drug interaction and its clinical implication","volume":"1830","author":"Yamasaki","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"2019110402561249400_gfz079-B28","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1124\/dmd.104.002782","article-title":"Bucolome, a potent binding inhibitor for furosemide, alters the pharmacokinetics and diuretic effect of furosemide: potential for use of bucolome to restore diuretic response in nephrotic syndrome","volume":"33","author":"Takamura","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"2019110402561249400_gfz079-B29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/bdd.1829","article-title":"A diclofenac suppository-nabumetone combination therapy for arthritic pain relief and a monitoring method for the diclofenac binding capacity of HSA site II in rheumatoid arthritis","volume":"34","author":"Setoguchi","year":"2013","journal-title":"Biopharm Drug Dispos"},{"key":"2019110402561249400_gfz079-B30","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1016\/j.chroma.2009.04.015","article-title":"Sodium octanoate to reverse indoxyl sulfate and p-cresyl sulfate albumin binding in uremic and normal serum during sample preparation followed by fluorescence liquid chromatography","volume":"1216","author":"de Loor","year":"2009","journal-title":"J Chromatogr A"},{"key":"2019110402561249400_gfz079-B31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000381008","article-title":"Enhanced indoxyl sulfate dialyzer clearance with the use of binding competitors","volume":"39","author":"Tao","year":"2015","journal-title":"Blood Purif"},{"key":"2019110402561249400_gfz079-B32","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/ndt\/gfn002","article-title":"Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition","volume":"23","author":"Nishio","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"2019110402561249400_gfz079-B33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0022-2275(20)36723-7","article-title":"Fatty acid binding to plasma albumin","volume":"16","author":"Spector","year":"1975","journal-title":"J Lipid Res"},{"key":"2019110402561249400_gfz079-B34","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.1021\/bi00080a032","article-title":"Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB","volume":"32","author":"Richieri","year":"1993","journal-title":"Biochemistry"},{"key":"2019110402561249400_gfz079-B35","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1248\/bpb.18.1755","article-title":"Characterization of binding site of uremic toxins on human serum albumin","volume":"18","author":"Sakai","year":"1995","journal-title":"Biol Pharm Bull"},{"key":"2019110402561249400_gfz079-B36","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1124\/dmd.112.045617","article-title":"Interaction between two sulfate-conjugated uremic toxins, p-cresyl sulfate and indoxyl sulfate, during binding with human serum albumin","volume":"40","author":"Watanabe","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"2019110402561249400_gfz079-B37","doi-asserted-by":"crossref","first-page":"962","DOI":"10.2337\/diacare.18.7.962","article-title":"Physiological modulation of plasma free fatty acid concentrations by diet: metabolic implications in nondiabetic subjects","volume":"18","author":"Wolever","year":"1995","journal-title":"Diabetes Care"},{"key":"2019110402561249400_gfz079-B38","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2337\/diab.37.8.1020","article-title":"Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"2019110402561249400_gfz079-B39","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1248\/yakushi.127.1805","article-title":"Need for pharmaceutical skill in using displacement of protein binding","volume":"127","author":"Takamura","year":"2007","journal-title":"Yakugaku Zasshi"},{"key":"2019110402561249400_gfz079-B40","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/clinchem\/47.5.901","article-title":"Heparin-induced release of protein-bound solutes during hemodialysis is an in vitro artifact","volume":"47","author":"De Smet","year":"2001","journal-title":"Clin Chem"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/34\/11\/1842\/30335834\/gfz079.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/34\/11\/1842\/30335834\/gfz079.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T19:31:39Z","timestamp":1663183899000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/34\/11\/1842\/5487284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,9]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,5,9]]},"published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfz079","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2019,5,9]]}}}